Broadfin Capital’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-4,361,291
| Closed | -$13M | – | 73 |
|
|
2016
Q3 | $13M | Buy |
4,361,291
+351,000
| +9% | +$1.04M | 1.16% | 23 |
|
|
2016
Q2 | $5.98M | Hold |
4,010,291
| – | – | 0.58% | 42 |
|
|
2016
Q1 | $14.8M | Buy |
4,010,291
+500,000
| +14% | +$1.85M | 1.43% | 16 |
|
|
2015
Q4 | $35.5M | Buy |
3,510,291
+1,189,925
| +51% | +$12M | 2.18% | 9 |
|
|
2015
Q3 | $31.6M | Sell |
2,320,366
-532,212
| -19% | -$7.24M | 1.76% | 9 |
|
|
2015
Q2 | $54.1M | Buy |
2,852,578
+350,000
| +14% | +$6.64M | 2.91% | 7 |
|
|
2015
Q1 | $65.5M | Sell |
2,502,578
-46,285
| -2% | -$1.21M | 5.1% | 4 |
|
|
2014
Q4 | $53.4M | Buy |
2,548,863
+1,542,301
| +153% | +$32.3M | 4.64% | 5 |
|
|
2014
Q3 | $33.6M | Buy |
1,006,562
+196,518
| +24% | +$6.56M | 3.52% | 9 |
|
|
2014
Q2 | $26M | Buy |
810,044
+460,044
| +131% | +$14.8M | 2.54% | 11 |
|
|
2014
Q1 | $16.2M | Buy |
+350,000
| New | +$16.2M | 1.57% | 21 |
|